Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjdementia
VJNeurology
Logo
  • Home (current)
  • Diseases
    Parkinson's Disease
    Multiple Sclerosis and Related Disorders
    Headache
    Amyotrophic Lateral Sclerosis
    Epilepsy
    Sleep Disorders
    Stroke
    Neuromuscular Disorders
    Movement Disorders
    View all Diseases
  • Topics
    Biology
    Diagnostics
    Trial Updates
    Treatment
    Prevention
    Surgery
    Imaging
    Genetics
    COVID-19
    View all Topics
  • Conferences
    EHC 2022
    AES 2022
    WSC 2022
    ECTRIMS 2022
    EHDN 2022
    MDS 2022
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Dimos-Dimitrios Mitsikostas

Elucidating the pathology of post COVID-19 headaches 3:28
Elucidating the pathology of post COVID-19 headaches
Dimos-Dimitrios Mitsikostas • 22 Mar 2022
Recent hot-button issues in headache research at CONy 2022 2:26
Recent hot-button issues in headache research at CONy 2022
Dimos-Dimitrios Mitsikostas • 22 Mar 2022
Upcoming trends and advances in headache treatment 1:34
Upcoming trends and advances in headache treatment
Dimos-Dimitrios Mitsikostas • 22 Mar 2022
Real-world effectiveness of fremanezumab for migraine prevention 1:23
Real-world effectiveness of fremanezumab for migraine prevention
Dimos-Dimitrios Mitsikostas • 15 Jun 2021
The future of migraine prevention with CGRP-targeted agents 2:14
The future of migraine prevention with CGRP-targeted agents
Dimos-Dimitrios Mitsikostas • 15 Jun 2021
Which treatment is optimal for migraine prevention? 1:40
Which treatment is optimal for migraine prevention?
Dimos-Dimitrios Mitsikostas • 15 Jun 2021
Comparing CGRP mAbs with preventive migraine standard of care: a likelihood to help or harm analysis 4:32
Comparing CGRP mAbs with preventive migraine standard of care: a likelihood to help or harm analysis
Dimos-Dimitrios Mitsikostas • 15 Jun 2021
Targeting CGRP for migraine prevention: the story so far 2:04
Targeting CGRP for migraine prevention: the story so far
Dimos-Dimitrios Mitsikostas • 15 Jun 2021
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJNeurology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJNeurology logo
The content of VJNeurology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy